press

Press03/15/2022

THE THIRD EUROPEAN MYELOMA NETWORK CONFERENCE: WHAT IS NEW IN THE FIELD OF MULTIPLE MYELOMA

Between 6 and 9 April, the world of Multiple Myeloma research will convene for a virtual meeting involving haematologists and clinical trial experts from Europe and beyond.
This virtual congress is promoted by the European EMN network, headquartered in Rotterdam, with the support of the Italian team in Turin, and in collaboration with the ER Congressi agency.
New therapeutic approaches aimed at increasing survival and quality of life of myeloma patients will be addressed. Sponsored sessions will provide a valuable overview of the new molecules and innovative therapeutic approaches.

The third edition of the European Myeloma Network Conference will take place from Wednesday 6 to Saturday 9 April, and it will be streamed on the emn2022 platform. As a pan-European network of excellence, EMN aims to promote collaboration between research centres and study groups across the continent, and ultimately to obtain quicker, more effective results in the treatment of plasma cell neoplasms.

Registrations (via the compilation of the module available on the emn2022 website) are discounted for “early birds” applying before 31 March 2022. The scientific sessions will be recorded and available on the emn2022 platform until 30 June 2022.

Where applicable, and contingent on the category specified during registration (medics, nurses, biologists, data mangers, researchers etc.), participants will obtain CME (Continual Medical Education) and EBAH (European Board for Accreditation in Haematology) credits. The press area of the website also features media accreditation for those interested in participating.

The four days of meeting (scheduled for the most part in the afternoon to favour those operating within the sector and often working in outpatients) constitute an intense conference programme. They are complemented by lectures and sessions detailing new therapeutic approaches, and strategies aimed at enhancing survival and quality of life for patients affected by Multiple Myeloma.

Of particular significance are the sponsored symposia, focusing on the progress related to the use of innovative molecules in clinical trials. In addition, the eight best abstracts submitted to the conference will be presented in a dedicated Oral Abstract session of the meeting, and all the submitted works will be published in the scientific journal HemaSphere.

The program coordinators are Professors Pieter Sonneveld (Rotterdam), Sonja Zweegman and Niels van de Donk (Amsterdam), representing the Netherlands; whilst their colleagues Professors Mario Boccadoro, Francesca Gay and Doctor Roberto Mina (Turin) will represent Italy during this important event. The international nature of the event is further evidenced by the five European countries of the conference scientific board: besides the EMN president Pieter Sonneveld (the Netherlands), and the vice president Prof. Mario Boccadoro (Italy), we have internationally renowned experts, such as Prof. Hermann Einsele (Germany), Prof. Maria-Victoria Mateos (Spain) and Prof. Philippe Moreau (France). More numerous still - from Europe and beyond - are the countries represented by the various speakers and chairpersons. Their collaboration provides further confirmation of the reach and international nature of the event.

Press
06/06/2019
EMN AT EHA SYMPOSIUM: BRINGING TOGETHER SCIENTIFIC COMMUNITY AND PHARMACEUTICAL INDUSTRY

In Amsterdam (June 13th 2019), a symposium chaired by Prof. Mario Boccadoro, Hematologist at the University of Turin, member of the European Myeloma Network and President of the Executive Committee of the EMN Research Italy Working Group, will deal with a very topical issue: the relationship between the scientific community and pharmaceutical companies – a highly relevant topic in the era of personalized medicine.

read more >
Press
02/16/2021
MULTIPLE MYELOMA: THE RESEARCH NEVER STOPS, WITH THE RESULTS ON VIEW AT THE SECOND CONGRESS OF THE EUROPEAN MYELOMA NETWORK

The Congress, initially scheduled for 2020 and postponed due to the pandemic, will now be a digital event. It will take place between 3 and 6 March and will connect haematologists and clinical trial experts across the continent.
The first edition, held at Turin’s Lingotto Congress Centre in April 2018, registered some 700 participants from 44 different countries.
Uniquely during this second edition, delegates will have the opportunity to interface directly with the speakers through instant chats.
The digital Congress is promoted by EMN International. It’s organized with the support of EMN Research Italy, the Italian operating branch of the EMN network, in collaboration with the ER Congressi agency.

read more >

COOKIES DISCLAIMER

This website uses cookies to improve your browsing experience. By continuing to browse this website, you agree to our use of cookies. Read the privacy policy